메뉴 건너뛰기
Genetic Programming and Evolvable Machines
Volumn 16, Issue 3, 2015, Pages 387-391
Software review: the KNIME workflow environment and its applications in genetic programming and machine learning
Author keywords

[No Author keywords available]
Indexed keywords

EID: 84939652748     PISSN: 13892576     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10710-015-9247-3     Document Type: Editorial
Times cited : (39)
References (7)
  • 1
    • 84879557098 scopus 로고    scopus 로고
    • KNIME: the Konstanz information miner
    • Preisach C, Burkhardt H, Schmidt-Thieme L, Decker R, (eds), Springer, Berlin
    • M.R. Berthold et al., KNIME: the Konstanz information miner, in Data analysis, machine learning and applications, ed. by C. Preisach, H. Burkhardt, L. Schmidt-Thieme, R. Decker (Springer, Berlin, 2008), pp. 319–326. doi:10.1007/978-3-540-78246-9_38
    • (2008) Data analysis, machine learning and applications , pp. 319-326
    • Berthold, M.R.1
  • 2
    • 77950408373 scopus 로고    scopus 로고
    • CDK-Taverna: an open workflow environment for cheminformatics
    • T. Kuhn, E.L. Willighagen, A. Zielesny, C. Steinbeck, CDK-Taverna: an open workflow environment for cheminformatics. BMC Bioinform 11, 159 (2010). doi:10.1186/1471-2105-11-159
    • (2010) BMC Bioinform , vol.11 , pp. 159
    • Kuhn, T.1    Willighagen, E.L.2    Zielesny, A.3    Steinbeck, C.4
  • 3
    • 84874910700 scopus 로고    scopus 로고
    • Drug discovery applications for KNIME: an open source data mining platform
    • M.P. Mazanetz, R.J. Marmon, C.B.T. Reisser, I. Morao, Drug discovery applications for KNIME: an open source data mining platform. Curr. Top. Med. Chem. 12, 1965–1979 (2012). doi:10.2174/1568026611212180004
    • (2012) Curr. Top. Med. Chem. , vol.12 , pp. 1965-1979
    • Mazanetz, M.P.1    Marmon, R.J.2    Reisser, C.B.T.3    Morao, I.4
  • 4
    • 84930617065 scopus 로고    scopus 로고
    • Understanding the foundations of the structural similarities between marketed drugs and endogenous human metabolites
    • S. O’Hagan, D.B. Kell, Understanding the foundations of the structural similarities between marketed drugs and endogenous human metabolites. Front Pharmacol 6, 105 (2015). doi:10.3389/fphar.2015.00105
    • (2015) Front Pharmacol , vol.6 , pp. 105
    • O’Hagan, S.1    Kell, D.B.2
  • 5
    • 84923682766 scopus 로고    scopus 로고
    • A ‘rule of 0.5′ for the metabolite-likeness of approved pharmaceutical drugs
    • S. O’Hagan, N. Swainston, J. Handl, D.B. Kell, A ‘rule of 0.5′ for the metabolite-likeness of approved pharmaceutical drugs. Metabolomics 11, 323–339 (2015). doi:10.1007/s11306-11014-10733-z
    • (2015) Metabolomics , vol.11 , pp. 323-339
    • O’Hagan, S.1    Swainston, N.2    Handl, J.3    Kell, D.B.4
  • 6
    • 84879897900 scopus 로고    scopus 로고
    • Open-source platform to benchmark fingerprints for ligand-based virtual screening
    • S. Riniker, G.A. Landrum, Open-source platform to benchmark fingerprints for ligand-based virtual screening. J. Cheminform. 5, 26 (2013). doi:10.1186/1758-2946-5-26
    • (2013) J. Cheminform. , vol.5 , pp. 26
    • Riniker, S.1    Landrum, G.A.2
  • 7
    • 84882310107 scopus 로고    scopus 로고
    • The Taverna workflow suite: designing and executing workflows of Web Services on the desktop, web or in the cloud
    • K. Wolstencroft et al., The Taverna workflow suite: designing and executing workflows of Web Services on the desktop, web or in the cloud. Nucl Acids Res 41, W557–W561 (2013). doi:10.1093/nar/gkt328
    • (2013) Nucl Acids Res , vol.41 , pp. W557-W561
    • Wolstencroft, K.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.